Clinical Trials

13 enrolled

Colorectal Neoplasms

NCT05084859 2024-08-09

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors

30 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT01307956 2023-10-26

Panitumumab, Combination Chemotherapy, & Radiation Therapy in Esophageal or Gastroesophageal Junction Cancer

11 enrolled 11 charts

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT03311750 2021-06-07

A-REPEAT

23 enrolled

Advanced Colorectal Cancer

NCT02448810 2021-05-25

Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer

115 enrolled 22 charts

Colorectal Neoplasms

NCT02015923 2021-03-16

CCRe-IV

Phase 4 Terminated

107 enrolled

Colonic Neoplasms, Neoplasm Metastasis

NCT03300609 2020-06-11

5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab

Phase 3 Terminated

4 enrolled

Colorectal Neoplasms

NCT01504477 2020-03-16

Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer

Phase 1/2 Terminated

6 enrolled 8 charts

Recurrence, Colorectal Neoplasms

NCT01057017 2020-02-17

First-Line FOLFOX-Bevacizumab for Advanced Colorectal Cancer With Wild-Type Ras

5 enrolled 7 charts

Colorectal Neoplasms

NCT01128387 2019-12-09

Trial of Panitumumab/Cisplatin/Fluorouracil Combined With Radiation in Esophageal Cancer

Phase 1/2 Terminated

11 enrolled 10 charts

Esophageal Neoplasms, Neoplasms

NCT02508077 2018-08-16

FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer

1 enrolled 4 charts

Colorectal Neoplasms

NCT01009983 2018-07-06

Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer

14 enrolled 11 charts

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01627379 2018-03-02

POWER

Phase 3 Terminated

300 enrolled

Esophageal Squamous Cell Carcinoma

NCT01508000 2016-10-12

BOS2

44 enrolled

Colorectal Neoplasms

NCT02199223 2016-09-22

Regorafenib + Panitumumab for Colorectal Cancers

2 enrolled

KRAS and NRAS Wild-type Colorectal Cancer

NCT00973193 2016-04-20

PrePaRad

20 enrolled

Adenocarcinoma, Neoplasms, Rectal Neoplasms

NCT01916109 2016-02-12

Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

4 enrolled 6 charts

Genitourinary

Cone Dystrophy 3, Urinary Bladder Neoplasms

NCT01296035 2015-08-25

PanGem

8 enrolled 6 charts

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01374789 2015-06-03

PURO

2 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT01038037 2014-12-04

Lung-TRIO

23 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01305772 2014-08-29

TOP0901

6 enrolled 6 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT01418742 2014-07-14

SKIP - A Double-blind Placebo-controlled Randomized Multicenter Trial of Skin Toxicity Treatment

11 enrolled

Colorectal Neoplasms

NCT00101907 2014-03-20

Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer

41 enrolled 17 charts

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Pancreatic Neoplasms

NCT00613730 2014-01-06

APPRISE 1

3 enrolled 5 charts

Pancreatic Neoplasms

NCT01017653 2013-09-04

Panitumumab and Irinotecan for Malignant Gliomas

16 enrolled 9 charts

CNSSarcoma

Glioblastoma, Glioma, Gliosarcoma

NCT00950820 2013-03-04

VOXEL

9 enrolled

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT00824785 2012-12-11

REAL3

Phase 3 Terminated

574 enrolled

Oesophago-gastric Cancer

NCT01262183 2012-05-11

PANORAMIC

4 enrolled